Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin Therapy in the Treatment of Dyslipidemia in Children With Steroid Sensitive Nephrotic Syndrome
NCT07497776Phase 4Completed
- Sponsor
- National Institute of Kidney Diseases and Urology
- Start
- Jan 2024
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of atorvastatin in dyslipidemia, sponsored by National Institute of Kidney Diseases and Urology. Started Jan 2024; status: completed.
02
Drugs
atorvastatin
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT07497776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07497776.